Stock data
Capricor Therapeutics, Inc. (CAPR)
Capricor Therapeutics, Inc. (CAPR) reported revenue of US$0.00M and net income of -US$105.04M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$108.14M | -US$105.04M | — |
| 2024 | US$22.27M | — | -US$42.56M | -US$40.47M | — |
| 2023 | US$25.18M | — | -US$24.08M | -US$22.29M | — |
| 2022 | US$2.55M | — | -US$29.70M | -US$29.02M | — |
| 2021 | US$0.24M | — | -US$20.94M | -US$20.02M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$40.73M | — |
| 2026-03-31 | — | -US$33.94M | — |
| 2025-12-31 | — | -US$30.17M | — |
| 2025-09-30 | — | -US$24.57M | — |
| 2025-06-30 | — | -US$25.91M | — |
| 2025-03-31 | — | -US$24.39M | — |
| 2024-12-31 | US$11.13M | -US$7.12M | — |
| 2024-09-30 | US$2.26M | -US$12.56M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.